Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
8(100.0%)
8Total
N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT04859725Not ApplicableRecruiting

HyperSpectral Imaging in Low Grade Glioma

Role: collaborator

NCT06571539Not ApplicableCompleted

Augmented Reality-Assisted Neurosurgical Drain Placement

Role: collaborator

NCT06026852Not ApplicableNot Yet Recruiting

Validation of Betalactam ML Prediction Models - TDMAide

Role: collaborator

NCT02408627Not ApplicableCompleted

EEG@HOME (Phase 3a of the Project, Comparison of EEG-recordings)

Role: collaborator

NCT02394639Not ApplicableWithdrawn

EEG@HOME (Phase 4 of the Project)

Role: collaborator

NCT02428348Not ApplicableTerminated

EEG@HOME (Phase 3b of the Project, Interviews)

Role: collaborator

NCT02408653Not ApplicableCompleted

EEG@HOME (Phase 2 of the Project, Measurements in Healthy Volunteers)

Role: collaborator

NCT02408666Not ApplicableCompleted

EEG@HOME (Phase 1 of the Project)

Role: collaborator

All 8 trials loaded